2008
DOI: 10.1007/s12253-008-9099-8
|View full text |Cite
|
Sign up to set email alerts
|

Voiding Symptoms and Urodynamic Findings in Patients with Modified Ileal Neobladde

Abstract: The aim of our study was to find the cause of urinary incontinence and voiding dysfunction in patients undergoing radical cystectomy and orthotopic bladder replacement with modified ileal neobladder (Reddy). Twenty-eight incontinent patients (operated on between 1988 and 2004) were involved in our examination. Based on the complaints of the patients, continence status was evaluated and divided into two groups: group I: partially incontinent (only night-time incontinence) n = 11 (39.3%) and group II: totally in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 37 publications
0
4
0
1
Order By: Relevance
“…Capacity of neobladder is an important factor for incontinence and involuntary contraction ( 11 ). The capacity of gastric neobladder like other neobladders might increase postoperatively ( 11 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Capacity of neobladder is an important factor for incontinence and involuntary contraction ( 11 ). The capacity of gastric neobladder like other neobladders might increase postoperatively ( 11 ).…”
Section: Discussionmentioning
confidence: 99%
“…Capacity of neobladder is an important factor for incontinence and involuntary contraction ( 11 ). The capacity of gastric neobladder like other neobladders might increase postoperatively ( 11 ). The final capacity of gastric neobladder can be determined six months ( 11 ) and one and a half years after the operation ( 12 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since BC contributes to the highest cost per patient from diagnosis to death and is the fifth most expensive cancer to treat; it might be an important goal to estimate the CoI in Hungary in order to provide local data for decisions on resource allocation.According to my best knowledge and review of the database of Hungarian journals (www.matarka.hu), Hungarian data is available regarding neither the HRQoL and CoI of BC patients; nor the cost-effectiveness of the applied therapies. Hungarian authors have published studies dealing with the therapies in BC, however, those were principally associated with diagnostic issues, risk assessment, survival, recurrence; and a few studies evaluated functional outcomesKondás et al, [1996];Samodai et al, [1996];Romics et al, [2006];Keszthelyi et al, [2009];Szűcs et al, [2012]).…”
mentioning
confidence: 99%
“…Το πιο συχνό σύμπτωμα των ασθενών αυτών είναι η ακράτεια ούρων και ειδικά η νυκτερινή μορφή της. Αναφερόμενα ποσοστά ημερήσιας ακράτειας κυμαίνονται από 0-65%, ενώ νυκτερινής 3%,7% ή και 97%[99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115] . Αυτές οι μεγάλες διακυμάνσεις μπορούν να αποδοθούν, κυρίως, σε διαφορετικές μεθοδολογικές πρακτικές εκτίμησης του εννοιολογικού προσδιορισμού της ακράτειας όσο και του χρονολογικού μετεγχειρητικού παραθύρου που αυτή διερευνήθηκε.…”
unclassified